Daito Pharmaceutical Co., Ltd.'s total assets for Q3 2024 were ¥76.63B, a decrease of -3.77% from the previous quarter. JP:4577 total liabilities were ¥25.01B for the fiscal quarter, a -9.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.